TE HEALTHCARE (06877) has announced that the Group expects to record a net consolidated loss attributable to shareholders of approximately HK$7.1 million for the fiscal year ending December 31, 2025. This stands in stark contrast to the net consolidated profit attributable to shareholders of approximately HK$11.3 million achieved in the previous fiscal year ending December 31, 2024. During the year ending December 31, 2025, the Group continued to expand its healthcare operations and successfully realized growth in its business-to-consumer (B2C) segment. Despite this expansion, the Group's overall profitability was adversely affected by a substantial increase in administrative and operational expenses resulting from the enlargement of its B2C sales channels and digital marketing initiatives. Furthermore, the Group incurred elevated professional and legal fees during the year, primarily associated with specific corporate transactions and ongoing litigation matters. Additionally, the Group anticipates reporting other income of approximately HK$4.6 million for the fiscal year ending December 31, 2025. This represents a significant decrease of about 71% compared to the other income of approximately HK$16.3 million recorded in the prior fiscal year, primarily due to lower levels of foreign exchange gains and interest-related income. The combined impact of these factors has led to the anticipated loss for the fiscal year ending December 31, 2025.